1. WHY WE EXIST
Markets differ across the globe but reports suggest that more than 20% of the world’s adult population suffer from pain-related disorders that would be remedied by some type of OTC analgesic.
The pain category is big, worth €19.3 billion, predictable (no seasonal impact) and is growing around +4.5% (aging population combined with the desire to stay active will continue to fuel growth). 70% of the volume is body pain meaning that to win in the pain category we must win in body.
2. HOW TO PRESENT THE SCIENCE BEHIND ALEVE
One of the main brand pillars is to be ‘Positively Enduring’, the upwards momentum of the wave device has been curated to communicate this. The following usages have been defined to help maintain this:

3. PRODUCT RANGE & POSITIONING
Superior body pain relief translated into each product proposition

4. ALEVE STORY
A brief history of our international evolution through the body pain segment
